ALBAMYCIN-T: AN IN VITRO TRIAL IN UGANDA.
D000150:Acinetobacter; D000900:Anti-Bacterial Agents; D002701:Chloramphenicol; D003353:Corynebacterium diphtheriae; D004755:Enterobacteriaceae; D004917:Erythromycin; D006193:Haemophilus influenzae; D006801:Humans; D066298:In Vitro Techniques; D007709:Klebsiella; D008089:Listeria monocytogenes; D009582:Nitrofurantoin; D009615:Nocardia; D009675:Novobiocin; D010406:Penicillins; D011511:Proteus; D011549:Pseudomonas; D012106:Research; D013210:Staphylococcus; D013291:Streptococcus; D013307:Streptomycin; D013449:Sulfonamides; D013752:Tetracycline; D014454:Uganda
D000900:Anti-Bacterial Agents; D010406:Penicillins; D013449:Sulfonamides; D009675:Novobiocin; D004917:Erythromycin; D002701:Chloramphenicol; C058849:albamycin T; D009582:Nitrofurantoin; D013752:Tetracycline; D013307:Streptomycin
CHLORAMPHENICOL; CORYNEBACTERIUM DIPHTHERIAE; ENTEROBACTERIACEAE; ERYTHROMYCIN; EXPERIMENTAL LAB STUDY; HAEMOPHILUS INFLUENZAE; KLEBSIELLA; LISTERIA MONOCYTOGENES; MIMAE; NITROFURANTOIN; NOCARDIA; NOVOBIOCIN; PARACOLOBACTRUM; PENICILLIN; PROTEUS; PSEUDOMONAS; STAPHYLOCOCCUS; STREPTOCOCCUS; STREPTOMYCIN; SULFONAMIDES; TETRACYCLINE; UGANDA